List of insiders holdings for ANI PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | MERIDIAN VENTURE PARTNERS II LP Meridian Venture Partners II GP L.P. Meridian Venture Partners II Co. Brown Robert E. JR 10% Owner | 2025-08-22 08:00:22 | 1,034,570 0 | 1,034,570 | Form 13D |
| 2 | SIMES STEPHEN M Vice Chairman, President & CEO | 2012-01-27 16:29:26 | 800,000 202,267 | 1,002,267 | Form 4 |
| 3 | EDELMAN JOSEPH PERCEPTIVE LIFE SCIENCES MASTER FUND LTD PERCEPTIVE ADVISORS LLC Cho Michael 10% Owner | 2004-12-13 16:48:36 | 709,819 0 | 709,819 | Form 13G |
| 4 | EDELMAN JOSEPH PERCEPTIVE LIFE SCIENCES MASTER FUND LTD PERCEPTIVE ADVISORS LLC 10% Owner | 2004-12-13 16:48:36 | 709,819 0 | 709,819 | Form 13G |
| 5 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | 2025-08-22 18:10:01 | 92,588 436,920 | 529,508 | Form 4 |
| 6 | Lalwani Nikhil PRESIDENT & CEO | 2025-08-14 17:48:48 | 411,219 0 | 411,219 | Form 4 |
| 7 | MARSHBANKS TRACY Director | 2018-05-16 16:22:18 | 0 349,934 | 349,934 | Form 4 |
| 8 | DONENBERG PHILIP B Sr VP of Finance, CFO, Secy | 2012-01-27 16:33:48 | 329,322 0 | 329,322 | Form 4 |
| 9 | RAYNOR DANIEL Director | 2018-03-19 16:54:29 | 0 289,003 | 289,003 | Form 4 |
| 10 | Gassert Chad SVP - CORP. DEV. & STRATEGY | 2025-08-18 16:29:10 | 73,615 173,226 | 246,841 | Form 4 |
| 11 | PRZYBYL ARTHUR President and CEO | 2020-04-08 17:54:20 | 190,309 0 | 190,309 | Form 4 |
| 12 | CAREY STEPHEN P. SVP & CFO | 2025-08-14 17:40:55 | 180,863 0 | 180,863 | Form 4 |
| 13 | Snabes Michael C Sr. VP of Medical Affairs | 2012-01-27 16:37:45 | 165,000 0 | 165,000 | Form 4 |
| 14 | LEHMAN LEAH M VP, Product Development | 2005-08-25 15:16:38 | 150,000 0 | 150,000 | Form 4/A |
| 15 | Marken James G. SVP OPS & PROD DEV | 2024-06-11 16:51:43 | 117,829 0 | 117,829 | Form 4 |
| 16 | SHERWIN STEPHEN A Director | 2012-03-30 17:27:49 | 111,760 0 | 111,760 | Form 4 |
| 17 | Mutz Christopher HEAD OF RARE DISEASE | 2025-05-15 20:10:46 | 107,317 0 | 107,317 | Form 4 |
| 18 | Schrepfer Robert W SVP - NEW BUS DEV & SPEC SALES | 2021-03-29 20:11:23 | 87,477 0 | 87,477 | Form 4 |
| 19 | Gutwerg Ori SVP, GENERICS | 2025-08-14 17:46:40 | 84,024 0 | 84,024 | Form 4 |
| 20 | SULLIVAN LOUIS W Director | 2012-03-30 17:38:22 | 82,898 0 | 82,898 | Form 4 |
| 21 | Jamnick Robert J. VP, Quality & Product Develop. | 2014-05-27 16:38:11 | 77,701 0 | 77,701 | Form 4 |
| 22 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | 2025-10-14 19:49:56 | 75,674 0 | 75,674 | Form 4 |
| 23 | HO ANGELA Director | 2004-03-22 15:48:29 | 72,137 0 | 72,137 | Form 4 |
| 24 | Walsh Patrick D Director | 2025-08-18 16:34:32 | 70,048 0 | 70,048 | Form 4 |
| 25 | Arnold Charlotte C. Vice President and CFO | 2016-04-11 19:10:16 | 62,298 0 | 62,298 | Form 4 |
| 26 | Davis Krista SVP, CHIEF HR OFFICER | 2025-09-22 17:14:59 | 60,186 0 | 60,186 | Form 4 |
| 27 | ROSENOW EDWARD C III Director | 2012-03-30 17:31:01 | 45,540 0 | 45,540 | Form 4 |
| 28 | KJAER PETER Director | 2010-04-02 16:26:51 | 44,425 0 | 44,425 | Form 4 |
| 29 | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | 2025-08-14 17:53:08 | 40,794 0 | 40,794 | Form 4 |
| 30 | NASH DAVID Director | 2023-05-24 16:31:13 | 38,561 0 | 38,561 | Form 4 |
| 31 | HAUGHEY THOMAS Director | 2025-08-14 17:38:38 | 36,521 0 | 36,521 | Form 4 |
| 32 | POTTS JOHN T JR Director | 2012-03-30 17:34:41 | 27,657 2,924 | 30,581 | Form 4 |
| 33 | TANNENBAUM RENEE P Director | 2025-05-27 18:17:20 | 26,957 0 | 26,957 | Form 4 |
| 34 | MANGANO ROSS J Director | 2014-09-16 16:40:57 | 26,914 0 | 26,914 | Form 4 |
| 35 | BELL STEVEN J VP Research & Pre-Clinical Dev | 2005-08-25 15:32:27 | 25,000 0 | 25,000 | Form 4/A |
| 36 | Thoma Jeanne Director | 2025-08-20 16:42:03 | 23,405 0 | 23,405 | Form 4 |
| 37 | Pera Antonio R Director | 2025-09-04 16:44:58 | 22,660 0 | 22,660 | Form 4 |
| 38 | Penn Thomas A. Director | 2019-04-01 16:00:21 | 16,710 0 | 16,710 | Form 4 |
| 39 | HOLUBOW FRED Director | 2018-03-22 17:00:35 | 16,144 0 | 16,144 | Form 4 |
| 40 | Leonard Matthew J Director | 2025-08-26 18:19:51 | 6,864 0 | 6,864 | Form 4 |
| 41 | LANKAU PETER A Director | 2016-04-11 18:58:16 | 4,500 0 | 4,500 | Form 4 |
| 42 | MORGENSTERN VICTOR A Director | 2007-06-14 16:53:13 | 0 0 | 0 | Form 4 |